← Leaderboards
Jenny Karlsson
Maas Biolab, Inc.
$2,128,359
Attributed
$2,128,359
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $912.8K · FY2007–10$1M$750K$500K$250K$0
'07
'08
'09
'10
Funding mix
By agency
NIH$2,128,359 · 1
By mechanism
U44$2,128,359 · 1
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Guidelines”
- Judith S. Currier · University Of California Los Angeles$272,240,505
- Lawrence Corey · Fred Hutchinson Cancer Center$207,121,712
- Michelle Vargas · Ppd Development Lp$176,419,297
- Norman Wolmark · Nsabp Foundation, Inc.$173,683,613
- Joseph J. Eron · Univ Of North Carolina Chapel Hill$172,075,623
- Daniel R Kuritzkes · Brigham And Women'S Hospital$135,335,138
Research focus
GuidelinesImmunosuppressive AgentsDoseDesignEnsureHistologyAmyotrophic Lateral SclerosisChromatographyClinical TrialsCyclosporinsDrug Delivery SystemsDrug KineticsBiomedical ResearchAffectBlood - Brain Barrier AnatomyAnimal TestingAreaBolus InfusionBrainAuthorization DocumentationBurden Of IllnessContinuous InfusionAnimal ModelImplant
Grant awards (4)
Intrathecal Cyclosporin for the Treatment of Amyotrophic Lateral Sclerosis (ALS)$890,731
U44 · FY2010 · NS · contact PI
Intrathecal Cyclosporin for the Treatment of Amyotrophic Lateral Sclerosis (ALS)$25,000
U44 · FY2009 · NS · contact PI
Intrathecal Cyclosporin for the Treatment of Amyotrophic Lateral Sclerosis (ALS)$912,761
U44 · FY2008 · NS · contact PI
Intrathecal Cyclosporin for the Treatment of Amyotrophic Lateral Sclerosis (ALS)$299,867
U44 · FY2007 · NS · contact PI